These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1028 related articles for article (PubMed ID: 28420185)

  • 1. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
    Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment.
    Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Najafi M; Sahebkar A
    J Cell Physiol; 2019 May; 234(5):5613-5627. PubMed ID: 30238978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin and Cancer Hallmarks.
    Talib WH
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targets of cancer drugs: Modulation by melatonin.
    Moloudizargari M; Moradkhani F; Hekmatirad S; Fallah M; Asghari MH; Reiter RJ
    Life Sci; 2021 Feb; 267():118934. PubMed ID: 33385405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin as an antioxidant: under promises but over delivers.
    Reiter RJ; Mayo JC; Tan DX; Sainz RM; Alatorre-Jimenez M; Qin L
    J Pineal Res; 2016 Oct; 61(3):253-78. PubMed ID: 27500468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential utility of melatonin in the treatment of childhood cancer.
    Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
    J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validity of melatonin as an oncostatic agent.
    Panzer A; Viljoen M
    J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the use of melatonin overcome drug resistance in cancer chemotherapy?
    Asghari MH; Ghobadi E; Moloudizargari M; Fallah M; Abdollahi M
    Life Sci; 2018 Mar; 196():143-155. PubMed ID: 29374563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin modulates tumor metabolism and mitigates metastasis.
    Reiter RJ; Sharma R; Tan DX; Huang G; de Almeida Chuffa LG; Anderson G
    Expert Rev Endocrinol Metab; 2023; 18(4):321-336. PubMed ID: 37466337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis.
    Reiter RJ; Sharma R; Ma Q; Rorsales-Corral S; de Almeida Chuffa LG
    Cell Mol Life Sci; 2020 Jul; 77(13):2527-2542. PubMed ID: 31970423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic mechanisms involved in the anti-cancer effects of melatonin.
    Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ
    Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin and cisplatin co-treatment against cancer: A mechanistic review of their synergistic effects and melatonin's protective actions.
    Rafiyan M; Davoodvandi A; Reiter RJ; Mansournia MA; Rasooli Manesh SM; Arabshahi V; Asemi Z
    Pathol Res Pract; 2024 Jan; 253():155031. PubMed ID: 38103362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.
    Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M
    Clin Transl Oncol; 2019 Mar; 21(3):268-279. PubMed ID: 30136132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin's Antineoplastic Potential Against Glioblastoma.
    Moretti E; Favero G; Rodella LF; Rezzani R
    Cells; 2020 Mar; 9(3):. PubMed ID: 32138190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases.
    Hosseinzadeh A; Alinaghian N; Sheibani M; Seirafianpour F; Naeini AJ; Mehrzadi S
    Life Sci; 2024 May; 344():122557. PubMed ID: 38479596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
    Reiter RJ
    Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation.
    Santoro R; Mori F; Marani M; Grasso G; Cambria MA; Blandino G; Muti P; Strano S
    Carcinogenesis; 2013 May; 34(5):1051-61. PubMed ID: 23354312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer.
    Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
    Curr Med Chem; 2017 Nov; 24(35):3829-3850. PubMed ID: 28721827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.